10 ML tranexamic acid 100 MG/ML Injection [Cyklokapron] — RxCUI 208104
RxNorm drug concept · Semantic branded drug
RxCUI 208104
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI208104
Official name10 ML tranexamic acid 100 MG/ML Injection [Cyklokapron]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asCyklokapron 1000 MG per 10 ML Injection; Cyklokapron 1000 MG in 10 ML Injection
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)144 prescriptions · 5 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Tranexamic Acid: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It depends on the form. As an IV injection, it's used short-term in people with hemophilia to control bleeding during and after a tooth extraction. As a tablet — brands include Lys...
- What exactly is tranexamic acid used for?
- No — this is a firm contraindication. Using tranexamic acid tablets at the same time as combined hormonal contraceptives (the pill, patch, or ring) significantly raises your risk o...
- Can I take the tablets if I'm on the pill or another hormonal birth control?
🕸️ Concept Web — How 10 ML tranexamic acid 100 MG/ML Injection [Cyklo... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
10 ML tranexamic acid 100 MG/ML Injection [Cyklokapron]
RxCUI 208104 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Tranexamic acid
10691IN
-
Tranexamic acid
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Cyklokapron
151568BN
-
Cyklokapron
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Tranexamic acid Injection
1789851SCDF -
Tranexamic acid Injectable Product
1157666SCDG -
Tranexamic acid Injection [Cyklokapron]
1789853SBDF -
Cyklokapron Injectable Product
1174439SBDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Tranexamic acid Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
10 ML tranexamic acid 100 MG/ML Injection
238720SCD -
Tranexamic acid 100 MG/ML
316849SCDC -
Tranexamic acid 100 MG/ML [Cyklokapron]
568832SBDC
-
10 ML tranexamic acid 100 MG/ML Injection
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
10 ML tranexamic acid 100 MG/ML Injection
SCD · 238720 -
Tranexamic acid 100 MG/ML
SCDC · 316849 -
Tranexamic acid Injection
SCDF · 1789851 -
Tranexamic acid Injectable Product
SCDG · 1157666
Brand-Name Concepts
-
Tranexamic acid 100 MG/ML [Cyklokapron]
SBDC · 568832 -
Tranexamic acid Injection [Cyklokapron]
SBDF · 1789853 -
Cyklokapron Injectable Product
SBDG · 1174439 -
Cyklokapron
BN · 151568
📦 FDA Products & Package NDCs
1 product · 2 package NDCs
2 package NDCs map to RxCUI 208104 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00013-1114-15 | 1 AMPULE in 1 CARTON (0013-1114-15) / 10 mL in 1 AMPULE (00... | Cyklokapron | Pfizer Laboratories Div Pfizer Inc | 2018-11-21 |
| 00013-1114-21 | 10 VIAL in 1 BOX (0013-1114-21) / 10 mL in 1 VIAL (0013-111... | Cyklokapron | Pfizer Laboratories Div Pfizer Inc | 1986-12-30 |
Observed labelers:
Pfizer Laboratories Div Pfizer Inc (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.